Search
for

    Research 10 of 20

    1. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm Advances in Therapy · 2017 · 77 citations
    2. The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo Journal of Dermatological Science · 2014 · 52 citations
    3. Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors 2022 · 12 citations
    4. Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata European Journal of Dermatology · 2019 · 10 citations
    5. Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review Dermatologic Therapy · 2020 · 9 citations
    6. Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata British Journal of Dermatology · 2019 · 5 citations
    7. Cytokine-targeted treatment in alopecia areata - new possibilities? Prospects in Pharmaceutical Sciences · 2023 · 1 citations
    8. Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature Nepal journal of dermatology, venereology & leprology · 2022 · 1 citations
    9. Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors? Journal of The European Academy of Dermatology and Venereology · 2020 · 1 citations
    10. Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions Springer eBooks · 2018
    All research results →

    Community 1

    1. The Worst Hair Loss Condition You (MAY) have: LPP Reddit · 31 Aug 2024

    Learn

    — no results

    Try a deeper search in learn →